Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study-Reference-Cited by-同舟云学术

Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

Published:2023-08 Issue:8 Volume:8 Page:714-725
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Vali Yasaman,Lee Jenny,Boursier Jerome,Petta Salvatore,Wonders Kristy,Tiniakos Dina,Bedossa Pierre,Geier Andreas,Francque Sven,Allison Mike,Papatheodoridis Georgios,Cortez-Pinto Helena,Pais Raluca,Dufour Jean-Francois,Leeming Diana Julie,Harrison Stephen A,Chen Yu,Cobbold Jeremy F,Pavlides Michael,Holleboom Adriaan G,Yki-Jarvinen Hannele,Crespo Javier,Karsdal Morten,Ostroff Rachel,Zafarmand Mohammad Hadi,Torstenson Richard,Duffin Kevin,Yunis Carla,Brass Clifford,Ekstedt Mattias,Aithal Guruprasad P,Schattenberg Jörn M,Bugianesi Elisabetta,Romero-Gomez Manuel,Ratziu Vlad,Anstee Quentin M,Bossuyt Patrick M

Funder

IMI

Horizon 2020

European Federation of Pharmaceutical Industries and Associations

Innovative Medicines Initiative

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis;Riazi;Lancet Gastroenterol Hepatol,2022

2. Defining comprehensive models of care for NAFLD;Lazarus;Nat Rev Gastroenterol Hepatol,2021